Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Randomized Study of Transarterial Chemoembolization Versus CyberKnife® for Recurrent Hepatocellular Carcinoma

NCT01318200 is registered in ClinicalTrials.gov with Accuray Incorporated as lead sponsor.

NCT NCT01318200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Randomized Study of Transarterial Chemoembolization Versus CyberKnife® for Recurrent Hepatocellular Carcinoma
Lead sponsor
Accuray Incorporated
Phase
Phase 3
Overall status
Withdrawn
Start date
February 28, 2011
Completion date
February 29, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent hepatocellular carcinoma